← back to search

Jianhua Chen

Shenyang Agricultural University · CN
Area of research
Applied Mathematics · Mathematical Physics
Research interest
Research interests include Nonlinear Partial Differential Equations, Advanced Mathematical Physics Problems, Nonlinear Differential Equations Analysis, and Lung Cancer Treatments and Mutations.
h-index
18
citations
2,257
works
134
NIH funding
primary concept
Medicine
email

Recent publications

Quasilinear Schrödinger equations with critical exponential growth in ℝ2: Existence and concentration behavior of solutions
Bulletin of Mathematical Sciences 2025cited by 3position: firstdoi
Abstract CT053: Aumolertinib with or without chemotherapy as first line treatment in locally advanced or metastatic NSCLC with sensitizing EGFR mutations (AENEAS2)
Cancer Research 2025cited by 3position: middledoi
Abstract CT138: Safety and efficacy of HS-10370 in KRAS G12C-mutated advanced solid tumors: Updated results from phase 1 study
Cancer Research 2025cited by 3position: middledoi
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, <i>EGFR</i> ‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS)
Cancer Communications 2024cited by 19position: middledoi
Critical fractional Schrödinger-Poisson systems with lower perturbations: the existence and concentration behavior of ground state solutions
Advances in Nonlinear Analysis 2024cited by 10position: middledoi
Abstract CT119: Safety and efficacy of HS-10370 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
Cancer Research 2024cited by 6position: middledoi
Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
Cancer Pathogenesis and Therapy 2024cited by 4position: middledoi
Normalized solutions for Chern-Simons-Schrödinger system with critical exponential growth
Journal of Mathematical Analysis and Applications 2024cited by 2position: lastdoi
Existence and Asymptotic Behaviour for the 2D-Generalized Quasilinear Schrödinger Equations Involving Trudinger–Moser Nonlinearity and Potentials
Journal of Geometric Analysis 2023cited by 5position: firstdoi
Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
Cancer Immunology Immunotherapy 2023cited by 5position: middledoi
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations
Journal of Clinical Oncology 2022cited by 271position: middledoi
Aumolertinib activity in patients with CNS metastases and EGFR-mutated NSCLC treated in the randomized double-blind phase III trial (AENEAS).
Journal of Clinical Oncology 2022cited by 15position: middledoi
Combined effects of concave and convex nonlinearities for the generalized Chern–Simons–Schrödinger systems with steep potential well and 1 &amp;lt; <i>p</i> &amp;lt; 2 &amp;lt; <i>q</i> &amp;lt; 6
Journal of Mathematical Physics 2022cited by 3position: lastdoi
Randomized phase III trial of aumolertinib (HS-10296, Au) versus gefitinib (G) as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and EGFR exon 19 del or L858R mutations (EGFRm).
Journal of Clinical Oncology 2021cited by 31position: middledoi
Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma
European Journal of Cancer 2021cited by 18position: middledoi
Penpulimab plus anlotinib as second-line treatment for the small cell lung cancer after failure of platinum-based systemic chemotherapy.
Journal of Clinical Oncology 2021cited by 11position: middledoi
Multiple solutions and ground state solutions for a class of generalized Kadomtsev-Petviashvili equation
Open Mathematics 2021cited by 1position: middledoi
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
The Lancet Oncology 2020cited by 579position: middledoi
Pyrotinib in <i>HER2</i>-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study
Journal of Clinical Oncology 2020cited by 203position: middledoi
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort
Translational Lung Cancer Research 2020cited by 117position: middledoi
The Schrödinger–Bopp–Podolsky Equation Under the Effect of Nonlinearities
Bulletin of the Malaysian Mathematical Sciences Society 2020cited by 17position: lastdoi
Existence and Concentration Behavior of Ground State Solutions for a Class of Generalized Quasilinear Schrödinger Equations in ℝN
Acta Mathematica Scientia 2020cited by 11position: firstdoi
Some results on standing wave solutions for a class of quasilinear Schrödinger equations
Journal of Mathematical Physics 2019cited by 15position: firstdoi
Ground state solutions for a class of quasilinear Schrödinger equations with Choquard type nonlinearity
Applied Mathematics Letters 2019cited by 14position: firstdoi
Existence and asymptotic behavior of standing wave solutions for a class of generalized quasilinear Schrödinger equations with critical Sobolev exponents
Asymptotic Analysis 2019cited by 11position: firstdoi
Positive Solutions for a Class of Quasilinear Schrödinger Equations with Two Parameters
Bulletin of the Malaysian Mathematical Sciences Society 2019cited by 7position: firstdoi
Positive solutions for a class of quasilinear Schrödinger equations with superlinear condition
Applied Mathematics Letters 2018cited by 13position: firstdoi
Some new inequalities of Simpson’s type for s-convex functions via fractional integrals
Filomat 2017cited by 66position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Xianjiu Huang · Nanchang University11 papers (2017–2025)Bitao Cheng · Nanchang University6 papers (2018–2023)Qiming Wang · Hunan Cancer Hospital3 papers (2020–2025)Jun Zhao · Beijing Institute of Technology3 papers (2020–2024)Gongyan Chen · Harbin Medical University3 papers (2020–2022)Chuanxi Zhu · Nanchang University3 papers (2019–2022)Xiaorong Dong · Lanzhou University Second Hospital3 papers (2021–2025)Qiang Liu · Stanford University2 papers (2021–2024)Juan Li · Hebei Medical University2 papers (2021–2022)Liying Gao · University of Illinois Urbana-Champaign2 papers (2021–2024)Zhuang Yu · Qingdao University2 papers (2021–2022)Chunling Liu · Xinjiang Medical University2 papers (2021–2022)Jianhua Shi · Harbin Medical University2 papers (2021–2022)Ziping Wang · Peking University2 papers (2021–2022)Yinghua Ji · Guilin Medical University2 papers (2021–2022)Rui Wang · Hebei Medical University2 papers (2021–2024)Shun Lü · Central South University2 papers (2021–2022)Kailiang Wu · Shanghai Medical College of Fudan University2 papers (2021–2024)Zhongyao Jia · Linyi People's Hospital2 papers (2021–2024)Xiangjiao Meng · Shandong University2 papers (2024–2025)